Clinics in South Dakota

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

What South Dakota law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

South Dakota at a glance

Pharmacy regulator: South Dakota Board of Pharmacy (South Dakota Department of Health)
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async unclear
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified clinics serving South Dakota

No verified clinics serving South Dakota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in South Dakota

Yes. A South Dakota resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a South Dakota-licensed prescriber, including through telehealth under SDCL chapter 34-52, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the South Dakota Board of Pharmacy, including a licensed nonresident pharmacy. SDCL 34-52 requires a proper provider-patient relationship with a diagnosis based on an examination before telehealth treatment, and South Dakota has no state bulks list, so peptide compounding eligibility follows the FDA framework. [1] [2] [3] [4] [5] [6]

Compounded GLP-1 access in South Dakota

South Dakota has not published a state rule that is looser than FDA policy. Because many South Dakota patients use mail order, confirming that the dispensing pharmacy holds a South Dakota nonresident license is the main practical check. [1] [3] [7]

Research use only sellers in South Dakota

SDCL chapter 36-11 reserves dispensing of prescription drugs to licensed pharmacies and pharmacists, so shipping "research use only" injectable peptides to South Dakota consumers is not a licensed pharmacy activity. [3] [8]

How to check a clinic in South Dakota

Confirm the prescribing clinician's license with the South Dakota medical or nursing board.
Ask which pharmacy compounds or dispenses the peptide and check it in the South Dakota Board of Pharmacy (South Dakota Department of Health) license lookup. [1] [3] [4] [5] [6]
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Dakota. [3] [8]

Common questions in South Dakota

Can I get a GLP-1 prescription in South Dakota through telehealth?

Yes, from a provider licensed in South Dakota who first establishes a proper provider-patient relationship under SDCL 34-52-3. That relationship requires identity verification, consent, a diagnosis based on examination and any needed tests, a discussion of options, and follow-up care. [2]

Does South Dakota allow prescribing from an online questionnaire?

SDCL 34-52-6 expressly bars prescribing a controlled substance solely from an internet questionnaire or telephone consult without an established relationship. GLP-1 drugs are not controlled, but SDCL 34-52-3 still requires an examination-based diagnosis, so a questionnaire-only model is unlikely to meet South Dakota's standard. [2]

All peptide legal questions for South Dakota